article thumbnail

The Financialization of Disruptive Technology

The Agile Manager

A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. Cheap capital makes it easy for anybody to enter the innovation game. Deep pocketed investors make it expensive to stay in the innovation game. Investment yields are highly concentrated.

article thumbnail

What I Read in 2017

Tim Kadlec

It’s fascinating to read about the different ways our technology-reliant world is vulnerable to attacks. Goodman doesn’t pull any punches, and he spends maybe 80% of the book outlining all the various technologies and how they leave us vulnerable. The setting is imaginative and full of unique biotech. It was, for the most part.

BioTech 45